Tech Company Financing Transactions
Domantis Funding Round
Domantis, based in Waltham, raised investment capital from 3i Venture Capital.
Transaction Overview
Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
200 Fifth Avenue
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Domantis is a drug discovery company developing the next generation of antibody molecules: Human Domain Antibodies. Domain Antibodies (dAbs) are therapeutic molecules that have benefits of both small molecules and conventional antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Connelly
Browse more venture capital transactions:
Prev: 3/31/2005: Ruckus Wireless venture capital transaction
Next: 3/31/2005: MDeverywhere venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs